Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus

Muh Geot Wong, Vlado Perkovic, Mark Woodward, John Chalmers, Qiang Li, Graham S. Hillis, Dania Yaghobian Azari, Min Jun, Neil Poulter, Pavel Hamet, Bryan Williams, Bruce Neal, Giuseppe Mancia, Mark Cooper, Carol A. Pollock

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Albuminuria and a reduced glomerular filtration rate are conventional predictors of a future decline in kidney function in patients with type 2 diabetes mellitus. Using a nested case-control study we assessed whether circulating transforming growth factor-β1 (TGF-β1) and bone morphogenetic protein-7 (BMP-7) levels more accurately predict renal end points than the conventional markers. Cases were defined as those who developed a renal end point (doubling of serum creatinine to at least 200 μmol/l, the need for renal replacement therapy, or death due to renal disease) during the study. Using propensity scoring, two controls were selected for each of 281 cases. Participants who developed renal end points had significantly higher total TGF-β1, lower BMP-7 levels, and a higher total TGF-β1 to BMP-7 ratio at baseline. A graded increase in risk was found in individuals with lower BMP-7 levels (odds ratio 24.07, for the lowest to the highest tertile), or significantly higher TGF-β1 levels (odds ratio for the highest to the lowest tertile, 8.43). The area under the receiver operating characteristic curve (c-statistic) for the conventional predictors was 0.73. Using BMP-7 and total and active TGF-β1, the c-statistic was 0.94 (significantly higher to conventional predictors). Thus, our results suggest these novel kidney markers are better predictors of renal progression than the conventional predictors in patients with type 2 diabetes mellitus.

Original languageEnglish
Pages (from-to)278-284
Number of pages7
JournalKidney International
Volume83
Issue number2
DOIs
Publication statusPublished - Feb 2013

Fingerprint

Bone Morphogenetic Protein 7
Transforming Growth Factors
Type 2 Diabetes Mellitus
Kidney
Odds Ratio
Albuminuria
Renal Replacement Therapy
Glomerular Filtration Rate
ROC Curve
Case-Control Studies
Creatinine
Serum

Keywords

  • albuminuria
  • chronic kidney failure
  • diabetic nephropathy

ASJC Scopus subject areas

  • Nephrology

Cite this

Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus. / Wong, Muh Geot; Perkovic, Vlado; Woodward, Mark; Chalmers, John; Li, Qiang; Hillis, Graham S.; Yaghobian Azari, Dania; Jun, Min; Poulter, Neil; Hamet, Pavel; Williams, Bryan; Neal, Bruce; Mancia, Giuseppe; Cooper, Mark; Pollock, Carol A.

In: Kidney International, Vol. 83, No. 2, 02.2013, p. 278-284.

Research output: Contribution to journalArticle

Wong, MG, Perkovic, V, Woodward, M, Chalmers, J, Li, Q, Hillis, GS, Yaghobian Azari, D, Jun, M, Poulter, N, Hamet, P, Williams, B, Neal, B, Mancia, G, Cooper, M & Pollock, CA 2013, 'Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus', Kidney International, vol. 83, no. 2, pp. 278-284. https://doi.org/10.1038/ki.2012.383
Wong, Muh Geot ; Perkovic, Vlado ; Woodward, Mark ; Chalmers, John ; Li, Qiang ; Hillis, Graham S. ; Yaghobian Azari, Dania ; Jun, Min ; Poulter, Neil ; Hamet, Pavel ; Williams, Bryan ; Neal, Bruce ; Mancia, Giuseppe ; Cooper, Mark ; Pollock, Carol A. / Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus. In: Kidney International. 2013 ; Vol. 83, No. 2. pp. 278-284.
@article{0fa7c3413a744340997a0d6fcef045ac,
title = "Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus",
abstract = "Albuminuria and a reduced glomerular filtration rate are conventional predictors of a future decline in kidney function in patients with type 2 diabetes mellitus. Using a nested case-control study we assessed whether circulating transforming growth factor-β1 (TGF-β1) and bone morphogenetic protein-7 (BMP-7) levels more accurately predict renal end points than the conventional markers. Cases were defined as those who developed a renal end point (doubling of serum creatinine to at least 200 μmol/l, the need for renal replacement therapy, or death due to renal disease) during the study. Using propensity scoring, two controls were selected for each of 281 cases. Participants who developed renal end points had significantly higher total TGF-β1, lower BMP-7 levels, and a higher total TGF-β1 to BMP-7 ratio at baseline. A graded increase in risk was found in individuals with lower BMP-7 levels (odds ratio 24.07, for the lowest to the highest tertile), or significantly higher TGF-β1 levels (odds ratio for the highest to the lowest tertile, 8.43). The area under the receiver operating characteristic curve (c-statistic) for the conventional predictors was 0.73. Using BMP-7 and total and active TGF-β1, the c-statistic was 0.94 (significantly higher to conventional predictors). Thus, our results suggest these novel kidney markers are better predictors of renal progression than the conventional predictors in patients with type 2 diabetes mellitus.",
keywords = "albuminuria, chronic kidney failure, diabetic nephropathy",
author = "Wong, {Muh Geot} and Vlado Perkovic and Mark Woodward and John Chalmers and Qiang Li and Hillis, {Graham S.} and {Yaghobian Azari}, Dania and Min Jun and Neil Poulter and Pavel Hamet and Bryan Williams and Bruce Neal and Giuseppe Mancia and Mark Cooper and Pollock, {Carol A.}",
year = "2013",
month = "2",
doi = "10.1038/ki.2012.383",
language = "English",
volume = "83",
pages = "278--284",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus

AU - Wong, Muh Geot

AU - Perkovic, Vlado

AU - Woodward, Mark

AU - Chalmers, John

AU - Li, Qiang

AU - Hillis, Graham S.

AU - Yaghobian Azari, Dania

AU - Jun, Min

AU - Poulter, Neil

AU - Hamet, Pavel

AU - Williams, Bryan

AU - Neal, Bruce

AU - Mancia, Giuseppe

AU - Cooper, Mark

AU - Pollock, Carol A.

PY - 2013/2

Y1 - 2013/2

N2 - Albuminuria and a reduced glomerular filtration rate are conventional predictors of a future decline in kidney function in patients with type 2 diabetes mellitus. Using a nested case-control study we assessed whether circulating transforming growth factor-β1 (TGF-β1) and bone morphogenetic protein-7 (BMP-7) levels more accurately predict renal end points than the conventional markers. Cases were defined as those who developed a renal end point (doubling of serum creatinine to at least 200 μmol/l, the need for renal replacement therapy, or death due to renal disease) during the study. Using propensity scoring, two controls were selected for each of 281 cases. Participants who developed renal end points had significantly higher total TGF-β1, lower BMP-7 levels, and a higher total TGF-β1 to BMP-7 ratio at baseline. A graded increase in risk was found in individuals with lower BMP-7 levels (odds ratio 24.07, for the lowest to the highest tertile), or significantly higher TGF-β1 levels (odds ratio for the highest to the lowest tertile, 8.43). The area under the receiver operating characteristic curve (c-statistic) for the conventional predictors was 0.73. Using BMP-7 and total and active TGF-β1, the c-statistic was 0.94 (significantly higher to conventional predictors). Thus, our results suggest these novel kidney markers are better predictors of renal progression than the conventional predictors in patients with type 2 diabetes mellitus.

AB - Albuminuria and a reduced glomerular filtration rate are conventional predictors of a future decline in kidney function in patients with type 2 diabetes mellitus. Using a nested case-control study we assessed whether circulating transforming growth factor-β1 (TGF-β1) and bone morphogenetic protein-7 (BMP-7) levels more accurately predict renal end points than the conventional markers. Cases were defined as those who developed a renal end point (doubling of serum creatinine to at least 200 μmol/l, the need for renal replacement therapy, or death due to renal disease) during the study. Using propensity scoring, two controls were selected for each of 281 cases. Participants who developed renal end points had significantly higher total TGF-β1, lower BMP-7 levels, and a higher total TGF-β1 to BMP-7 ratio at baseline. A graded increase in risk was found in individuals with lower BMP-7 levels (odds ratio 24.07, for the lowest to the highest tertile), or significantly higher TGF-β1 levels (odds ratio for the highest to the lowest tertile, 8.43). The area under the receiver operating characteristic curve (c-statistic) for the conventional predictors was 0.73. Using BMP-7 and total and active TGF-β1, the c-statistic was 0.94 (significantly higher to conventional predictors). Thus, our results suggest these novel kidney markers are better predictors of renal progression than the conventional predictors in patients with type 2 diabetes mellitus.

KW - albuminuria

KW - chronic kidney failure

KW - diabetic nephropathy

UR - http://www.scopus.com/inward/record.url?scp=84873405796&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873405796&partnerID=8YFLogxK

U2 - 10.1038/ki.2012.383

DO - 10.1038/ki.2012.383

M3 - Article

C2 - 23235570

AN - SCOPUS:84873405796

VL - 83

SP - 278

EP - 284

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 2

ER -